Ductal carcinoma in situ of the breasts: Over‐diagnosis, over‐treatment and a decade of lost direction
Precision Medical Sciences · 2020
DOI: 10.1002/prm2.12008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Medical Sciences, 2020. Verfasst von Michael Co. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ductal carcinoma in situ (DCIS) of the breast is the earliest detectable form of breast cancer. Mainstay of treatment is complete surgical removal with or without adjuvant radiotherapy. Incidence of DCIS has increased significantly over the last decade; however, increased surgical removal of DCIS has not resulted in the decreased incidence of invasive breast cancer. Whether or not we are over‐treating ductal carcinoma in situ (DCIS) with complete surgical removal of the tumor has been subjected to much debate.
Zitieren
APA
Co, M. (2020). Ductal carcinoma in situ of the breasts: Over‐diagnosis, over‐treatment and a decade of lost direction. Precision Medical Sciences. https://doi.org/10.1002/prm2.12008
Vancouver
Co M. Ductal carcinoma in situ of the breasts: Over‐diagnosis, over‐treatment and a decade of lost direction. Precision Medical Sciences. 2020. doi:10.1002/prm2.12008
BibTeX
@article{Co2020,
author = {Co, Michael},
title = {Ductal carcinoma in situ of the breasts: Over‐diagnosis, over‐treatment and a decade of lost direction},
journal = {Precision Medical Sciences},
year = {2020},
doi = {10.1002/prm2.12008}
}
EUVIMED